Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1
Condition(s):Neurofibromatosis 1Last Updated:July 12, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Neurofibromatosis 1Last Updated:July 12, 2023Recruiting
Condition(s):Neurofibromatosis Type 1Last Updated:May 3, 2018Completed
Condition(s):Neurofibromatosis Type 1Last Updated:June 25, 2012Unknown status
Condition(s):Cutaneous NeurofibromaLast Updated:November 3, 2023Active, not recruiting
Condition(s):Neurofibromatosis 1; Diagnoses Disease; Post Traumatic Stress DisorderLast Updated:October 2, 2017Completed
Condition(s):Neurofibromatosis Type 1Last Updated:April 14, 2020Terminated
Condition(s):Neurofibromatosis 1; Neurofibromatosis 2; SchwannomatosisLast Updated:August 30, 2023Recruiting
Condition(s):Neurofibromatosis 1Last Updated:November 22, 2016Completed
Condition(s):Neurofibromatosis 1Last Updated:January 31, 2019Completed
Condition(s):Neurofibromatosis Type 1Last Updated:July 11, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.